Discovery of new vaccine approach for treatment of cancer
The findings were published online in Cancer Research
2012-01-30
(Press-News.org) Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental Immunology at Trinity College Dublin discovered a new approach for treating the disease based on manipulating the immune response to malignant tumours. The discovery has been patented and there are plans to develop the vaccine for clinical use for cancer patients.
The first cancer vaccine Sipuleucel-T (Provenge™) was licensed last year for use in prostate cancer patients unresponsive to hormone treatment. Unfortunately, this cell based vaccine only improves patient survival by an average of 4.1 months. Vaccines for infectious diseases are highly effective at generating immune responses that prevent infection with bacteria or viruses. The immune system can also protect us against tumours and in theory a vaccine approach should be effective against cancer. In practice this has proven very difficult because unlike infectious diseases, tumours are derived from normal human cells, and not made up of foreign substances or antigens capable of triggering an immune response. The tumours instead produce molecules that suppress the efficacy of the immune system. They generate regulatory cells that inhibit the immune response that could potentially clear the tumours.
Professor Mills' group has developed a novel vaccine and immunotherapeutic approach that can overcome these obstacles and has the potential to significantly improve on existing technologies. The therapy is based on a combination of molecules that manipulates the immune response to curb the regulatory arm while enhancing the protective arm, allowing the induction of specialist white blood cell called killer T cells to target and eliminate the tumours. The new vaccine approach was found to be highly effective at pre-clinical stage in treating a range of cancers in murine models.
The findings were published in December online in Cancer Research, the leading journal of The American Association of Cancer Research. The research was performed by a Senior Postdoctoral Fellow Dr Neil Marshall, at Trinity College Dublin, with the help of two PhD students, Anna-Maria Corcoran and Karen Galvin and was funded by a Science Foundation Ireland Principal Investigator award to Professor Mills. The discoveries have been patent protected and Professor Mills has plans to translate them to the clinic via a TCD Campus Company, TriMod Therapeutics that he co-founded with Dr Jeremy Skillington.
INFORMATION:
For a copy of the Cancer Research article click on: http://cancerres.aacrjournals.org/content/early/2011/12/09/0008-5472.CAN-11-0307.abstract
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-01-30
Winston-Salem, N.C. – Jan. 27, 2012 – Bedwetting isn't always due to problems with the bladder, according to new research by Wake Forest Baptist Medical Center. Constipation is often the culprit; and if it isn't diagnosed, children and their parents must endure an unnecessarily long, costly and difficult quest to cure nighttime wetting.
Reporting online in the journal Urology, researchers found that 30 children and adolescents who sought treatment for bedwetting all had large amounts of stool in their rectums, despite the majority having normal bowel habits. After treatment ...
2012-01-30
North Shore property owners made a clear statement in 2011 by consistently selecting Kazawest as their property management firm of choice. The company's services have become the first preference for many properties seeking to improve customer service, property maintenance and market value.
Through its integrated real estate services, strength in customer service and excellence building operations, Kazawest (http://www.kazawest.com) is establishing itself as the clear leader of the property management industry in British Columbia.
Kazawest's CEO, Amyn Somani, commented ...
2012-01-30
DURHAM, N.C. – Hundreds of rare, endemic species in the Central Andes remain unprotected and are increasingly under threat from development and climate change, according to a Duke University-led international study.
"These species require unique ecological conditions and are particularly vulnerable to changes in the environment or climate. Yet our analysis shows that region-wide, about 80 percent of the areas with high numbers of these species lack any protection," said Jennifer Swenson, assistant professor of the practice of geospatial analysis at Duke's Nicholas School ...
2012-01-30
WINSTON-SALEM, N.C. – Jan. 27, 2012 – An itch is just an itch. Or is it?
New research from Gil Yosipovitch, M.D., Ph.D., professor of dermatology at Wake Forest Baptist Medical Center and a world-renowned itch expert, shows that how good scratching an itch feels is related to the itch's location.
While previous studies by Yosipovitch have shown the pleasurability of itching, analysis of itch relief at different body sites and related pleasurability had not been performed until now. The study was published online this month by the British Journal of Dermatology.
"The ...
2012-01-30
Research Now, the leading global online sampling and data collection company, today announced the appointment of Melanie Courtright to Vice President of Research Services. Melanie is based out of the company's headquarters in Plano, Texas.
Courtright brings with her over 16 years of experience serving clients in the research sector, having commenced her career with an eleven-year stint at NOVO 1, where she held several senior roles including Vice President of Client Services. She later joined DMS Research, an AOL company, where she played an integral role in the creation ...
2012-01-30
HOUSTON - When SUMO grips STAT5, a protein that activates genes, it blocks the healthy embryonic development of immune B cells and T cells unless its nemesis breaks the hold, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
"This research extends the activity of SUMO and the Sentrin/SUMO-specific protease 1 (SENP1) to the field of immunology, in particular the early lymphoid development of T and B cells," said the study's senior author, Edward T. H. Yeh, M.D., professor and chair of MD Anderson's Department ...
2012-01-30
The new "restyled" Federal Rules of Evidence went into effect December 1, 2011. While the stated criteria for the amendments emphasizes that no substantive changes to the traditional Rules of Evidence are intended, the rules have in fact been substantially rewritten. Terminology and phrasing have been changed and modernized, and a new outline-style subsection reorganization has been effected throughout. While the substantive result of evidentiary issues might be the same under either the traditional or restyled rules, locating or citing the applicable provisions ...
2012-01-30
TCN Worldwide is pleased to announce Laurence Elbaum, principal and co-founder of Bradford Allen Realty Services/TCN Worldwide of Chicago and chairman of the TCN Worldwide Board of Directors, has been inducted into Midwest Real Estate News' Commercial Real Estate Hall of Fame.
Having received more than 300 nominations the highly regarded publication recently announced their newest inductees into the Midwest Commercial Real Estate Hall of Fame. As stated by Midwest Real Estate News, "These are men and women who have not only succeeded in one of the most challenging ...
2012-01-30
One day in 2010, Rutgers physicist Vitaly Podzorov watched a store employee showcase a kitchen gadget that vacuum-seals food in plastic. The demo stuck with him. The simple concept – an airtight seal around pieces of food – just might apply to his research: developing flexible electronics using lightweight organic semiconductors for products such as video displays or solar cells.
"Organic transistors, which switch or amplify electronic signals, hold promise for making video displays that bend like book pages or roll and unroll like posters," said Podzorov. But traditional ...
2012-01-30
Deacom, Inc., producer of the DEACOM Enterprise Resource Planning (ERP) software system for mid-to-large sized batch process manufacturing companies launched its new website today.
The new website, http://www.deacom.com, was designed to communicate Deacom's overall message of Complexity Made Simple to employees, customers, potential customers and the world at large. The new website outlines the capabilities of the DEACOM ERP software package offerings and explains the philosophies behind its development. Deacom has a unique niche in the ERP software industry and the ...
LAST 30 PRESS RELEASES:
[Press-News.org] Discovery of new vaccine approach for treatment of cancer
The findings were published online in Cancer Research
